Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Gilead ordered to pay $200m to Merck in patent row
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: AstraZeneca suffers setback with its blood thinner
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Johnson & Johnson to pay $498M over hip implant injuries
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: AstraZeneca reworks executive pay and revenue goals
Pharmalot By Ed Silverman Why, in the age of Martin Shkreli, patients are still happy with pharma companies
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Insurers investigated over hep C drug coverage, Valeant exec resigns
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Drug makers accused of misleading medical journal on blood thinner
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Glaxo searching for new CEO, Valeant CEO returns from illness
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Some investors losing confidence in Valeant, Sanofi abandoning allergy med